Bright Green CORP 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
Bright Green Corporation's Q3 2024 report highlights ongoing efforts to establish its federally-authorized cannabis business, with no revenue reported and continued focus on facility development and regulatory compliance.
Bright Green Corporation reported its Q2 2024 results, highlighting ongoing development and strategic shifts towards plant-based medicines, while navigating financial challenges.
Bright Green Corporation, a federally authorized cannabis company, reported its first quarter 2024 results with a net loss of $949,450 and no revenue, while continuing to develop its facilities and expand into other controlled substances.